1,284 transcripts
Page 8 of 65
njv
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
and results anticipated in forward-looking statements. These risk factors include those contained in ChromaDex's annual report on Form 10-K most recently
ch23
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
release as well as in our Form 10-K filed with the SEC. And with that, I'll turn it back over to Jacqui.
Thanks, Peter. I'd now like to open up
tn
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
Report on Form 10-K and quarterly report on Form 10-Q. The company's SEC filing are available on the Investors section of our website.These forward-looking
u7
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
fourth quarter 2023 corporate update press release filed yesterday and our annual report on Form 10-K filed this morning as well as in other reports
cy
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
expressed or implied in these statements. These include risks and other factors outlined in our filings with the SEC, including our 10-K, which
ep
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
refer you to the section entitled Risk Factors in our most recent annual report on Form 10-K which provides a discussion of important factors and risks
6ej7
Earnings call transcript
NYSE
2024 Q1
6 Mar 24
, among others, matters that we've described in our Form 8-K filed with the SEC earlier today and other filings we make with the SEC. We disclaim any
8vmb
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
on the earnings press release as well as in the company's 2022 10-K, which was filed on March 16, 2023 with the SEC.
Additionally, the company may discuss
yu
Earnings call transcript
NYSE
2024 Q4
6 Mar 24
more fully in the company's press release and reports filed with the SEC, including the most recently filed Form 10-K or Form 10-Q.Any changes
hta9
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
Form 10-K for the year ended December 31, 2023. The company undertakes no obligation to publicly update or revise any forward-looking statements
5ky
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
, including, without limitation, the company's Forms 20-F and 6-K, which identify specific factors that may cause actual results or events to differ
a6
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
-K and Form 10-Q or any updates at our current reports on Form 8-K filed with the U.S. Securities and Exchange Commission and InspireMD's press release
06
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
with our collaboration with them on our allogeneic platform. Two components to that, and these are laid out in the 10-K. The first are anniversary
gkm
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
can find reconciliation tables to the most comparable GAAP figures in our press release and 10-K filed with the SEC today. Turning to our financial
kox
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
and uncertainties affecting the company as described in the Risk Factors section and in other sections included in the company's annual report on Form 10-K filed
s1da
Earnings call transcript
NYSE
2023 Q4
6 Mar 24
segments. GAAP financials are included in our press release and 10-K that will be filed in the coming months and contain results that include our
lvyl
Earnings call transcript
NASDAQ
2024 Q4
5 Mar 24
release, which may be found on the Investor Relations website at ir.crowdstrike.com or on our Form 8-K filed with the SEC today.
With that, I will now
8sas
Earnings call transcript
NYSE
2023 Q4
5 Mar 24
issued today as well as risks described in our annual report on Form 10-K, particularly in the section of these documents titled Risk Factors.Our
vo
Earnings call transcript
NASDAQ
2023 Q4
5 Mar 24
markets may not happen as anticipated as well as other risks described in Socket's most recent Form 10-K and 10-Q reports filed with the Securities
c8b
Earnings call transcript
NASDAQ
2023 Q4
5 Mar 24
and uncertainties described under the Risk section included in Plus Therapeutics' annual report on Form 10-K and quarterly reports on Form 10-Q filed